2 years ago
NVAX
AnalystsBrendan SmithBrendan Smith's Stock Forecasts
AnalystsBrendan Smith
Analyst Ranking
Top 45%
#2264 out of 5116 analysts
Average Return
+12.01%
Win Rate
60%3 out of 5
Risk vs Reward
Poor
Good
Brendan Smith's 5 best and worst ratings
Brendan Smith Analyst Color
Get additional color on Brendan Smith's coverage of popular stocks
Brendan Smith's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Novavax IncNVAX | 2 | Hold | $7.00 | -0.71% | Maintains | a month ago |
West Pharmaceutical Services IncWST | 1 | Strong Buy | $350.00 | +26.24% | Initiates Coverage On | a month ago |
Simulations Plus IncSLP | 1 | Hold | $16.00 | -5.88% | Initiates Coverage On | 2 months ago |
Ginkgo Bioworks Holdings IncDNA | 1 | Strong Buy | $10.00 | N/A | Maintains | a year ago |
Halozyme Therapeutics IncHALO | 2 | Strong Buy | $65.00 | N/A | Maintains | a year ago |
Denali Therapeutics IncDNLI | 1 | Buy | N/A | N/A | Initiates Coverage On | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.